43 Biotech Startups in Cambridge to Watch in 2024
How do we build this list?
Last update to the database: May 26, 2024. See changelog.
Join 23,000+ founders, operators and investors.
Seedtable Score Learn how we calculate it here
We use raw data and human intuition to understand if a company is likely to outsource services like Hiring, Design, Development, etc.
company | score | funding | investors | employees | industries | biz model | city | contact |
---|---|---|---|---|---|---|---|---|
Bioinformatics discovery platform. |
$8M · Series A | Future Fund | 1 to 10 | Biotech, Data and Analytics | B2B, SaaS | Cambridge, UK | •••••••••••@plaquetec.com | |
Human microbiome therapeutics developer creating live bacterial treatments and biomarkers. |
$66M | Seventure Partners, Cambridge Innovation Capital | 11 to 50 | Health Tech, Biotech, Deep Tech, Manufacturing | B2B | Cambridge, UK | •••••••••••@microbiotica.com | |
Drug delivery platform. |
$24M · Series A | 4BIO Capital, UCB Ventures, Business Growth Fund | 1 to 10 | Health Tech, Biotech | Cambridge, UK | •••••••••••@vianautis.com | ||
Platform for discovering new drugs for rare diseases using AI technology. |
$56M · Series B | Balderton Capital, Atomico, btov Partners | 51 to 100 | Health Tech, AI, Biotech, Pharma, Data and Analytics, Business Intelligence | B2B, SaaS | Cambridge, UK | •••••••••••@healx.io | |
AI platform to advance precision medicine clinical trials. |
$11M · Series A | Seedcamp, Plural, Episode 1 | 11 to 50 | Health Tech, Biotech | B2B, SaaS | Cambridge, UK | •••••••••••@sanogenetics.com | |
DNA synthesis technology researcher. |
$24M · Series B | Foresite Capital | 11 to 50 | Biotech | Cambridge, UK | •••••••••••@evonetix.com | ||
Anti-cancer drug developer. |
$28M · Series A | Syncona Partners LLP, Cambridge Innovation Capital | 101 to 250 | Biotech | Cambridge, UK | •••••••••••@mosaic-tx.com | ||
Genomic data analysis platform. |
$2M · Seed | We Venture Capital, Nina Capital, LinkedIn | 11 to 50 | Biotech, Data and Analytics | B2B, SaaS | Cambridge, UK | •••••••••••@zettagenomics.com | |
Platform enabling the development of cell therapies through advanced reprogramming techniques. |
$10M · Series A | Astellas Venture Management, Parkwalk Advisors, Ahren Innovation Capital | 101 to 250 | Health Tech, Biotech, Deep Tech | B2B | Cambridge, UK | •••••••••••@mogrify.co.uk | |
Physiological upregulation therapy to treat neurodegenerative diseases. |
$5M · Seed | SV Health Investors | 11 to 50 | Health Tech, Biotech | Cambridge, UK | •••••••••••@harnesstx.com | ||
Genomics company building safer cell and gene therapies. |
$15M · Series A | Tencent, Illumina Ventures | 1 to 10 | Health Tech, Biotech | Cambridge, UK | •••••••••••@brokenstringbio.com | ||
Platform for understanding and defining the biological codes that make up human cells. |
$41M · Series A | Metaplanet Holdings, BlueYard Capital | 101 to 250 | Health Tech, Biotech, Deep Tech, Business Intelligence | B2B | Cambridge, UK | •••••••••••@bit.bio | |
Desktop technology making biology accessible by synthesizing proteins and genes. |
$42M · Series B | Future Planet Capital, Amadeus Capital, Verve Ventures | 11 to 50 | Biotech, Deep Tech, Manufacturing | B2B | Cambridge, UK | •••••••••••@nuclera.com | |
Platform that helps manage and analyze life sciences data for organizations. |
$3M · Seed | ETF Partners, Granpool Innovative Investments | 11 to 50 | Health Tech, Biotech | B2B | Cambridge, UK | •••••••••••@eaglegenomics.com | |
Pet therapeutics startup dedicated to developing medicines for pets. |
$13M · Series A | Cambridge Innovation Capital, Parkwalk Advisors | 1 to 10 | Health Tech, Biotech, Deep Tech, Pharma | B2B | Cambridge, UK | •••••••••••@petmedix.co.uk | |
Cancer immunotherapeutics company working across the Atlantic. |
$13M · Seed | Cambridge Innovation Capital | 1 to 10 | Health Tech, Biotech, Deep Tech, Pharma | B2B | Cambridge, UK | •••••••••••@epitopea.com | |
Deubiquitylating enzyme (DUB) drug discovery and development platform. |
$6M · Series A | Sofinnova Partners, Rosetta Capital, Pfizer Venture Investments | 51 to 100 | Health Tech, Biotech | Cambridge, UK | •••••••••••@missiontherapeutics.com | ||
Drug manufacturer. |
$10M · Series A | Biospring Partners | 501 to 1000 | Health Tech, Biotech, Pharma | B2B, SaaS | Cambridge, UK | •••••••••••@abzena.com | |
Live human cell cultures and genome editing services for researchers. |
$5M | Calculus Capital | 11 to 50 | Health Tech, Biotech, Pharma, Business Intelligence | B2B | Cambridge, UK | •••••••••••@axolbio.com | |
Fibroblast technology designed to develop new therapies for diseases. |
$11M · Seed | GV, Forbion Capital Partners | 1 to 10 | Health Tech, Biotech, Deep Tech, Manufacturing | B2B | Cambridge, UK | •••••••••••@mestagtx.com | |
Manufacturer of growth factor proteins for stem cell, organoid and cellular agriculture applications. |
$5M · Series B | Parkwalk Advisors, Downing Ventures | 11 to 50 | Biotech, Deep Tech | Cambridge, UK | •••••••••••@qkine.com | ||
Plant-based biodegradable material producer. |
$2M · Seed | Amadeus Capital, Horizons Ventures, Parkwalk Advisors | 1 to 10 | Biotech | B2B | Cambridge, UK | •••••••••••@xampla.com | |
Biological sensor enabling quick and affordable detection of biological substances. |
$2M · Seed | Parkwalk Advisors | 1 to 10 | Hardware, Biotech, Manufacturing, Business Intelligence | B2B | Cambridge, UK | •••••••••••@hexagonfab.com | |
Platform utilizing microfabrication technology to create smart materials for innovative cell testing. |
$2M · Seed | Parkwalk Advisors, Martlet Capital | 1 to 10 | Health Tech, Biotech, Manufacturing | B2B | Cambridge, UK | •••••••••••@semarion.com | |
Drug discovery platform focused on restoring mitochondrial function through therapeutic approaches. |
$18M | 1 to 10 | Health Tech, Biotech, Pharma | B2B | Cambridge, UK | •••••••••••@nrgtherapeutics.com | ||
Platform for increasing protein production in the body using specialized translation enhancers. |
$12M · Seed | 11 to 50 | Health Tech, Biotech, Deep Tech | B2B | Cambridge, UK | •••••••••••@transinetx.com | ||
Wearable device that offers non-invasive medical technology. |
$692k · Pre Seed | Amadeus Capital, Parkwalk Advisors | 11 to 50 | Health Tech, Hardware, Biotech, Manufacturing | B2B | Cambridge, UK | •••••••••••@charconeurotech.com | |
CardiaTec is a digital biotechnology venture combining the power of AI and expert talent to redesign cardiovascular drug discovery. |
$1M · Pre Seed | 1 to 10 | Health Tech, AI, Biotech, Deep Tech, Pharma | B2B | Cambridge, UK | •••••••••••@cardiatec.ai | ||
Clinical stage studies to discover biomarkers to improve medical diagnosis. |
$2M · Seed | 1 to 10 | Health Tech, Biotech | Cambridge, UK | •••••••••••@upfrontdiagnostics.com | |||
Genomic technology developer to detect biomarkers for non-small cell lung cancer (NSCLC). |
$940k · Seed | Octopus Ventures, Longwall Venture, BlueYard Capital | 11 to 50 | Health Tech, Biotech | B2B | Cambridge, UK | •••••••••••@biofidelity.com | |
The food chain is broken. Our technology fixes it. |
$791k · Pre Seed | Balderton Capital, Fly Ventures | 11 to 50 | Agritech, Foodtech, Biotech, Manufacturing | B2B | Cambridge, UK | •••••••••••@betterorigin.co.uk | |
Platform identifying chemical starting points to speed up drug discovery at lower costs. |
$2M · Seed | 1 to 10 | Health Tech, Biotech, Deep Tech, Pharma, Business Intelligence | B2B, SaaS | Cambridge, UK | •••••••••••@pharmenable.com | ||
Platform for life science professionals to connect with global experts for strategic engagement. |
$3M | 51 to 100 | Health Tech, Biotech, Deep Tech, Pharma, Business Intelligence | B2B, SaaS | Cambridge, UK | •••••••••••@monocl.com | ||
Diagnostic decision support platform for biotechnology applications. |
N/A | QVentures, Cambridge Innovation Capital, Parkwalk Advisors | 11 to 50 | Health Tech, Biotech, Genetics | B2B | Cambridge, UK | •••••••••••@congenica.com | |
A digital fertility clinic for men providing personalized care and services. |
N/A | 101 to 250 | Health Tech, Biotech, Proptech & Real Estate, Femtech, Mobile, Energy & Nuclear, Genetics, Business Intelligence, Fertility | B2B, SaaS | Cambridge, UK | •••••••••••@givelegacy.com | ||
Biotechnology company focused on targeting deubiquitinase enzymes for cancer therapy. |
N/A | 1 to 10 | Biotech, Deep Tech | Cambridge, UK | •••••••••••@cellcentric.com | |||
A full-stack neural interface platform, that uses AI to decode and encode the signals from to the body, to treat chronic health conditions. |
N/A | 11 to 50 | Biotech, Data and Analytics | Cambridge, UK | •••••••••••@bios.health | |||
An innovator in life science reagents and tools serving life science researchers globally to achieve their mission, faster. |
N/A | 1001 to 5000 | Biotech, Deep Tech | Cambridge, UK | •••••••••••@abcam.com | |||
A multi-disciplinary team, based in Cambridge, working to solve some of the most difficult problems in biotechnology. |
N/A | 11 to 50 | Biotech, Deep Tech | Cambridge, UK | •••••••••••@base4.co.uk | |||
Biotechnology platform transforming food waste into sustainable resources using insects. |
N/A | 1 to 10 | Biotech, Energy & Nuclear | Cambridge, UK | •••••••••••@entomics.com | |||
Technology for accelerating vaccine development and achieving significant improvements. |
N/A | 11 to 50 | Biotech, Deep Tech | Cambridge, UK | •••••••••••@diosvax.com | |||
Developer of gene therapies to treat focal refractory epilepsy. |
$10M · Seed | UCL Technology Fund, HTH | 1 to 10 | Health Tech, Biotech | Cambridge, UK | •••••••••••@epilepsygtx.com | ||
AI-driven drug discovery platform for rare diseases. |
$47M · Series C | Balderton Capital, Atomico, btov Partners | 51 to 200 | AI, Biotech | B2B, SaaS | Cambridge, UK | •••••••••••@healx.ai |
Sign up to access our full database
Enter your email and get access to 18,000+ technology companies you can partner with.